jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Antimony

Hormone/ Element
image

Report in 12Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Heavy metal test for antimony levels.

2,3093,298

30% OFF

Antimony Test - Comprehensive Medical Information Guide

  • Why is it done?
    • Detects antimony exposure and accumulation in the body from occupational, environmental, or medicinal sources
    • Monitors individuals with occupational exposure in mining, smelting, battery manufacturing, or chemical industries
    • Evaluates potential toxicity from chronic antimony exposure or accidental poisoning
    • Assesses exposure from medications containing antimony compounds used to treat leishmaniasis and schistosomiasis
    • Investigates unexplained symptoms potentially related to antimony exposure (respiratory issues, gastrointestinal problems, dermatologic manifestations)
    • Conducts baseline and periodic screening for workers in high-risk occupations
  • Normal Range
    • Reference Values: Blood (serum/plasma) antimony levels in unexposed individuals typically range from <0.5 to 2.0 µg/L (micrograms per liter)
    • Urine Levels: Normal 24-hour urine antimony excretion is typically <10 µg/L (micrograms per liter)
    • Interpretation of Results:
    • Normal/Negative: Antimony levels below reference range indicate minimal to no exposure or toxicity
    • Elevated: Levels above upper limit of normal suggest occupational or environmental exposure, therapeutic drug use, or potential toxicity
    • Significantly Elevated (>10-20 µg/L): May indicate acute or chronic exposure with potential clinical consequences
    • Units of Measurement: µg/L (micrograms per liter), µg/dL (micrograms per deciliter), or ng/mL (nanograms per milliliter) depending on laboratory
  • Interpretation
    • Low/Normal Levels (<0.5-2.0 µg/L):
    • Indicates minimal antimony exposure and no evidence of toxicity
    • Worker or patient can continue normal activities without antimony-related health concerns
    • Mildly Elevated Levels (2.0-5.0 µg/L):
    • Suggests occupational or environmental exposure, may be from mining, manufacturing, or therapeutic use
    • Requires monitoring and evaluation of exposure source; may warrant workplace or medication review
    • Clinical symptoms may be minimal or absent at this level
    • Moderately Elevated Levels (5.0-15.0 µg/L):
    • Indicates significant occupational or environmental exposure requiring investigation and intervention
    • May be associated with subclinical effects on pulmonary, cardiovascular, or gastrointestinal systems
    • Recommendations include exposure reduction, engineering controls, and increased surveillance
    • Highly Elevated Levels (>15.0 µg/L):
    • Suggests acute or chronic toxic exposure requiring immediate medical attention and intervention
    • Associated with clinical toxicity symptoms including respiratory disease, gastrointestinal disorders, cardiac arrhythmias
    • Requires immediate cessation of exposure, medical evaluation, and potential chelation therapy
    • Factors Affecting Results:
    • Occupational exposure history and workplace safety measures
    • Current or recent therapeutic antimony medication use (potassium antimony tartrate, meglumine antimoniate)
    • Environmental exposure from contaminated water or food sources
    • Time since last exposure; antimony has relatively long biological half-life (days to weeks)
    • Renal function and hydration status affecting elimination
    • Individual baseline antimony levels may vary geographically
  • Associated Organs
    • Primary Organ Systems Affected:
    • Respiratory System: Inhalation of antimony dust/fumes causes pneumoconiosis (antimony silicosis), chronic bronchitis, reduced lung function, interstitial fibrosis
    • Gastrointestinal System: Exposure causes nausea, vomiting, abdominal pain, diarrhea, anorexia, and potential ulceration
    • Cardiovascular System: May cause myocarditis, arrhythmias, QT prolongation, hypotension, and myocardial damage
    • Hepatic System: Acute or chronic exposure may cause hepatic dysfunction, elevated liver enzymes, fatty infiltration
    • Renal System: Exposure can result in proteinuria, decreased glomerular filtration rate, and potential renal dysfunction
    • Integumentary System: Dermatitis, sensitization, allergic contact dermatitis, and skin irritation from contact exposure
    • Nervous System: Peripheral neuropathy, tremor, and neurological effects in cases of severe exposure
    • Associated Diseases and Conditions:
    • Antimony Pneumoconiosis: Occupational lung disease from chronic inhalation of antimony dust
    • Antimony-Related Myocarditis: Toxic inflammation of heart muscle, particularly from antimonial drugs
    • Heavy Metal Poisoning: Acute toxicity from high-dose exposure or accidental ingestion
    • Leishmaniasis/Schistosomiasis Treatment Effects: Adverse effects from therapeutic pentavalent antimony compounds
    • Chronic Obstructive Pulmonary Disease (COPD): Exacerbation or contribution from occupational antimony exposure
    • Contact Dermatitis and Occupational Skin Disorders
    • Potential Complications:
    • Progressive respiratory insufficiency and hypoxemia in pneumoconiosis
    • Sudden cardiac death from acute myocarditis or severe arrhythmias
    • Acute hepatic failure in severe poisoning
    • Acute kidney injury and chronic renal impairment
    • Electrolyte imbalances and metabolic derangements
  • Follow-up Tests
    • Recommended Follow-up Tests Based on Elevated Results:
    • Chest X-ray and High-Resolution CT Chest: Evaluate for pneumoconiosis, fibrosis, and respiratory complications
    • Pulmonary Function Tests (PFTs): Assess lung capacity, airflow obstruction, and diffusion capacity
    • 12-Lead Electrocardiogram (ECG): Screen for QT prolongation, arrhythmias, and myocardial changes
    • Transthoracic Echocardiogram (TTE): Evaluate cardiac structure and function if myocarditis suspected
    • Liver Function Tests (LFTs): Measure AST, ALT, bilirubin, and alkaline phosphatase to assess hepatic injury
    • Comprehensive Metabolic Panel (CMP): Evaluate renal function, electrolytes, glucose, and other parameters
    • Urinalysis: Screen for proteinuria and evaluate renal involvement
    • Complete Blood Count (CBC): Assess for anemia or hematologic abnormalities
    • Other Heavy Metal Screening: Test for lead, cadmium, arsenic, or other occupational exposures
    • Monitoring and Frequency:
    • Occupational Workers: Annual or biennial screening depending on exposure level and regulatory requirements
    • Therapeutic Drug Use: Monitor at baseline, mid-treatment, and post-treatment periods
    • Elevated Levels: Repeat testing after 3-6 months to assess clearance or continued exposure
    • Post-Exposure: Serial testing to document levels returning to baseline after exposure cessation
    • Complementary Tests:
    • 24-Hour Urine Antimony Collection: More reflective of recent exposure than single blood sample
    • Serum and Urine Antimony Speciation: Differentiates trivalent vs pentavalent antimony if available
    • Hair Analysis: May provide long-term exposure history though less specific than blood/urine
    • Occupational History and Exposure Assessment: Workplace evaluation and environmental sampling
  • Fasting Required?
    • Fasting Requirement: No
    • Explanation: Fasting is not required for antimony testing as food intake does not significantly interfere with serum or urine antimony measurement
    • Sample Collection Instructions:
    • Blood Sample: Collect 5-10 mL of venous blood in a metal-free tube (typically plastic or silicone-coated tube to avoid contamination)
    • Urine Sample: 24-hour urine collection in acid-washed, metal-free collection bottle; alternatively, spot urine sample may be acceptable
    • Pre-Test Preparation:
    • No specific fasting required; patient can eat and drink normally
    • Patient should maintain normal medication schedule unless specifically instructed otherwise by healthcare provider
    • Avoid direct skin contact with antimony-containing materials immediately before testing if possible
    • Inform healthcare provider of current medications, especially those containing antimony or affecting kidney function
    • Medications to Avoid or Report:
    • Medications containing antimony compounds (pentavalent antimony preparations for leishmaniasis/schistosomiasis) - disclose to laboratory
    • No medications need to be specifically withheld for antimony testing
    • Special Considerations:
    • Ensure proper specimen collection using specialized metal-free containers to prevent contamination
    • Proper chain of custody and rapid transport to laboratory is important to maintain sample integrity
    • For occupational screening, timing of blood draw relative to work shift may affect results (end-of-shift samples may be higher)
    • Document any recent occupational or environmental exposures in patient history

How our test process works!

customers
customers